ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2019

Clinical potential of liraglutide in cardiovascular risk reduction in patients with type 2 diabetes: evidence to date.

Rebecca Howell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.